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Poster Session-II 135Follow up for infections was censored at time of relapse or death.
Hazard ratios (HR) of outcome of patients with above vs below me-
dian immune subset count at the beginning of each interval were de-
termined. The HR was adjusted for disease stage, stem cell source,
immunosuppressive therapy for GVHD, and use of antimicrobial
prophylaxis. Due to multiple comparisons, HR was considered sig-
nificant only if p\0.01.
Results:No association was found between an immune cell subset
count and fatal infection, non-relapse mortality, survival, or relapse.
Regarding infections, the only significant association between a day
30 subset count and day 30–80 infections was betweenCD4-CD8-T
cells and viral infections. For the subsequent time intervals, conspic-
uous associations are shown in Table 1.
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Conclusion: In contrast to previous studies, no association was
found between an immune cell subset count and fatal infection,
non-relapse mortality, survival, or relapse. Associations between
some immune cell subset counts and infections exist and should be
further studied.377
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Viral infections (CMV, EBV and Adenovirus) can be fatal compli-
cations post allogeneic hematopoietic stem cell and solid organ
transplantation. Administration of virus-specific CTLs, targeting in-
dividual- or multiple-viral antigens is effective in these patients.
However, in those whose immunosuppressive treatment needs to
be maintained to prevent GvHD or organ rejection, expansion and
persistence of adoptively transferred virus-specific CTLs are im-
paired. FK506 is frequently used as immunosuppressive drug. Its ef-
fects depend on binding to FKBP12 proteins. SinceT cells generated
from FKBP12 knockout mice are resistant to the inhibitory effects of
FK506, we knocked down FKBP12 using a small interfering RNA
(siRNA) to generate virus- specific CTLs resistant to FK506. As
a model we used EBV1 tumor and EBV-CTLs. We identified one
siRNA sequence (siRNA4), that knocked down .90% of FKBP12
expression in T cell lines and virus-CTLs. We then generated 2 ret-
roviral vectors encoding for siRNA4/eGFP and irrelevant siRNA/
eGFP and used them to transduce CTLs generated from 7 EBV-
seropositive donors. Transduction efficiency was 46 6 22% for
siRNA4 and 556 27% for irrel.-siRNA. We measured the prolifer-
ation of transduced CTLs in the presence of FK506, in short and
long term cultures. We found that in the presence of FK506, prolif-
eration of control CTLs was significantly inhibited (by 746 2%) as
compared to siRNA41 CTLs (41 6 4%). In long term cultures,modified CTLs were stimulated weekly with EBV1 cells, with or
without FK506 (5ng/ml) and low dose IL-2 (20U/mL). The propor-
tion of siRNA41CTLs increased over time not only as a percentage
of GFP1 cells (from 466 22% to 896 5% after 5 stimulations) but
also numerically (34median fold expansion, range 5–60). In contrast,
control CTLs did not show any selection in culture, as the percent-
age of GFP1 cells remained unchanged (from 56 6 27% to 57 6
23%) and CTLs ceased to proliferate (2 median fold expansion,
range 0–5). Finally, we found that siRNA41 CTLs retained their
MHC-restricted cytotoxicity against EBV1 cells (66 6 22% lysis
at an E:T ratio of 20:1). Modified CTLs also maintained their pro-
duction of IFN-g in response to EBV-peptides, as assessed by ELI-
spot assays. In conclusion, we have developed a strategy that
produces virus-specific CTLs resistant to FK506. This strategy
may be beneficial to improve virus immune reconstitution in patients
post transplant, despite ongoing immunosuppresion.378
ASSOCIATION BETWEEN HLA-E POLYMORPHISM AND SEVERE FUNGAL
INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
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HLA-E is a non classical HLA class I molecule that interacts with
NK cell CD94/NKG2 family receptors as a major ligand playing
a dual role in NK cell modulation and T cell activation, either inhib-
iting or triggering the citotoxicity by these cells. These roles indicate
the involvement of HLA-E antigen in host-immune response against
pathogens. The aim of this studywas to evaluate whether theHLA-E
alleles have functional impact on the incidence of bacterial, viral and
fungal infections in patients who have undergone an HLA identical
sibling myeloablative hematopoietic stem cell transplantation
(HSCT). One hundred and seven patients and their respective do-
nors were included in this study. HSCT was performed from 1999
to 2006, with a minimum of 6 months follow up. The distinction be-
tween HLA-E*0101 and HLA-E*0103 alleles was done either by
polymerase chain reaction – restriction fragment length polymor-
phism (PCR-RFLP) and polymerase chain reaction – sequence spe-
cific primer (PCR-SSP). The predictive effect of HLA-E genotype
(HLA-E* 0101/ E*0101, E* 0101/E* 0103 and E*0103/ E*0103)
was assessed as variables.Univariate analysis using death as a compet-
ing risk were done to evaluate the association between HLA-E poly-
morphism with first infections episodes. HLA-E genotype showed
no association with severe bacterial infection or viral infections.
However, in first severe fungal infection episode HLA-E* 0101/
E*0101 genotype was found to have a protective effect (P 5 0.01),
since none of the patients who had severe fungal infections had
this haplotype. In conclusion, it is possible that HLA-E genotype
polymorphism fulfills a related function to fungal infection after
HSCT, although these are preliminary data and need further
confirmation.379
A ROLE FOR IRAK-M IN PGE2-INDUCED IMMUNOSUPPRESSION POST-
BONE MARROW TRANSPLANT
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Rationale: Following bone marrow (BM) transplantation (BMT),
patients are susceptible to lung infections. In a mouse model of syn-
geneic BMT, we have shown BMT alveolar macrophages (AMs) and
alveolar epithelial cells (AECs) overproduce prostaglandin E2
(PGE2) relative to non-transplant controls. Overproduction of
PGE2 significantly impairs neutrophil killing and inhibits both
phagocytosis and killing in AMs. These defects are also associated
with diminished TNF-alpha production. However, a mechanism
by which PGE2 overproduction suppresses lung innate immune
cell function post-BMT is unknown. As interleukin-1 receptor asso-
ciated kinase (IRAK)-M is a known inhibitor of MyD88-dependent-
136 Poster Session-IITLR signaling and AM function, we sought to determine whether
IRAK-M was involved in PGE2-induced immunosuppression post-
BMT.
Methods: IRAK-M protein and mRNA expression were mea-
sured in AMs from control and BMT mice. Additionally, control
AMs cultured in the presence or absence of 100 nM PGE2 were an-
alyzed for IRAK-M expression. To study the role of IRAK-M post-
BMT, we transplanted either wild-type (WT) BM or IRAK-M-/-
BM into WT recipients. Levels of PGE2 were measured in AMs
five weeks post-BMT. BMT and control mice were also challenged
with P. aeruginosa infection and bacterial burden was measured in
the lung and blood 24 hours later.
Results: BMT AMs displayed elevated IRAK-M expression rela-
tive to non-transplant control AMs. Treatment of control AMs with
PGE2 upregulated IRAK-MmRNA and protein expression. Despite
overproduction of PGE2, IRAK-M-/-.WT BMT mice displayed
improved host defense against P. aeruginosa lung infection com-
pared to WT.WT BMT mice.
Conclusions: PGE2 may impair host defense against P. aerugi-
nosa in BMT AMs via upregulation IRAK-M. Strategies to limit
IRAK-M elevation post-BMT may prove efficacious in limiting in-
fections post-BMT.380
PLASMACYTOID CD1231 DENDRITIC CELL RECOVERY AND REDUCED
ACTIVATION STATE OF CIRCULATING CD81 T CELLS PREDICT SURVIVAL
AFTER UNRELATED CORD BLOOD TRANSPLANT (UCBT)
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Background: Reconstitution of adaptive immunity is critical for
long term survival following HCT. UCBT is a suitable option for
those who lack HLA-matched sibling donors. Antigen presenting
dendritic cells (DC) and lymphocytes are critical for acquiring pro-
tective immunity. Infections remain the major cause of TRM. In
the COBLT study, successful recovery of antiviral cellular immunity
was associated with a reduced rate of relapse.
Methods: Between July 2005, and December 2007, 95 children
with full donor chimerism following myeloablative conditioning
and a single cord UCBT were assessed for reconstitution of DC
andT cell subsets, B andNK cells at 3, 6, 12, 24, and 36months after
UCBT to analyze their impact on overall survival (OS).
Results: 52 and 43 children were transplanted for non-malig-
nant and malignant diseases, respectively. The median age was
2.7 years, 55 patients were male, 38 (40%) were 4/6, 39 (41%)
were 5/6 and 18 (19%) were 6/6 HLA match. The median in-
fused TNC and CD341 cell dose was 7.2  107/kg and 1.9 
105/kg, respectively. Of the 95 patients, 6 died before day 180,
11 died between day 180 and 365 [1-year survival probability
81.7% (95% CI 72.2%-88.2%)], and 8 died between day 365
and 730 [2-year survival probability 69.1% (95% CI 57.1%-
78.3%)]. In an univariate analysis of OS post-transplant, non-ma-
lignant diagnosis (HR 5 0.25, p 5 0.001), HLA match of 5/6 or
6/6 (HR 5 0.41, p 5 0.02), absolute number of CD1231 ‘‘plas-
macytoid’’ dendritic cells (pDC) .8 cells/ul (HR 5 42, p 5
0.04), %CD45RA1/CD62L1 ‘‘recent thymic emigrants’’ .13%
(HR 5 0.41, p 5 0.02), %HLA-DR1/CD81 T cells \19%
(HR 5 0.25, p 5 0.01) were each associated with a decreased
risk of death, while ‘‘myeloid’’ DC and other lymphocyte recovery
had no statistical impact. In this cohort where all studied patients
have successfully engrafted, gender, race, CMV serology, TNC,
CD341 cell dose, and TBI had no impact. In multivariate
models non-malignant disease remained a predictor for better
OS. (HR 5 0.27, p 5 0.002). Two immune parameters remained
significant predictors of survival when patient and graft specific
variables were included in multivariate analysis; abs# of
CD1231 pDC .8 cells / ul (p 5 0.05) and %HLA-DR1/
CD81 T cells \19% (p 5 0.01).
Conclusion: This is the first analysis to suggest that the absolute
number of CD1231 pDC .8 Cells /ul is an independent predictor
of survival after UCBT. Independently, lower activation state of
CD81 T cells also correlates with superior survival.Table 1. Univariate andmultivariate analysis of overall survival
(OS).
Hazard Ratio P-valueUnivariate Model
GenderFemale 1.52 0.3
Male 1.00Disease
Non-Malignant 0.25 0.001
Malignant 1.00Cell Doses
TNC / kg 1.03 0.4
CD341 / kg 1.01 0.9HLA Match
5 / 6 or 6 / 6 0.41 0.02
4 / 6 1.00Cell Type
Absolute Number of CD1231DC (pDC / ul) 0.42 0.04
CD45RA1/CD62L1 ‘‘Recent Thymic
Emigrants’’ .13%0.41 0.02%HLA-DR1/CD81 T cells\19% 0.25 0.01
Multivariate ModelDisease
Non-Malignant 0.27 0.002
Malignant 1.00HLA Match
5 / 6 or 6 / 6 0.53 0.1
4 / 6 1.00Cell Type
Absolute Number of CD1231 (pDC / ul) 0.44 0.05
HLA-DR1/CD81 T Cells\19% 0.29 0.01381
HOMEOSTATIC MECHANISMS AFFECT RECONSTITUTION OF CD41
FOXP31 REGULATORY T CELLS AFTER HEMATOPOIETIC STEM CELL
TRANSPLANTATION
Matsuoka, K.-i., Kim, H.T., McDonough, S., Herrera, M., Cutler, C.S.,
Koreth, J., Reynolds, C., Antin, J.H., Soiffer, R.J., Ritz, J. Dana-Farber
Cancer Institute, Harvard Medical School, Boston, MA
CD41FoxP31 regulatory T cells (Treg) play a critical role in im-
mune tolerance after allogeneic HSCT but the homeostatic mecha-
nisms that affect Treg reconstitution post-HSCT have not been
identified. To address this issue we simultaneously examined pheno-
typic and functional characteristics of Treg and CD41FoxP3- con-
ventional T cells (Tcon) in peripheral blood after allogeneic HSCT
(n 5 16, median 10 months post-HSCT). Post-HSCT Treg ex-
pressed higher levels of mitotic marker Ki-67 than Tcon (median
5.2% vs 1.5%; p\0.0001) and Treg from normal donors (median
5.2% vs 2.5%; p 5 0.03). %Ki-671 Treg was inversely correlated
with peripheral CD4 count (r5 -0.86, p\0.0001). To assess survival
of Treg, we purified 4 different CD41 T cell subsets by cell sorting
(CD45RA1 Tcon, CD45RA- Tcon, CD45RA1 Treg and
CD45RA- Treg) from 4 healthy donors, 8 patients post-autologous
and 8 post-allogeneicHSCT. Each subset was cultured with or with-
out agonistic FAS antibody and apoptosis was measured using An-
nexin-V staining. Anti-FAS rapidly induced apoptosis of
CD45RA- Treg from patients (median 25.3%) while all other
Treg and Tcon (median 4.5%, p\0.0001) subsets were relatively re-
sistant to apoptosis. The degree of memory CD45RA- Treg apopto-
sis is equivalent after autologous and allogeneicHSCT, but inversely
correlated with the peripheral lymphocyte count in the patient (r 5
-0.54, p 5 0.03). The effect of lymphopenia was also evaluated by
prospectively monitoring Treg and Tcon recovery 3–24 months
post-HSCT in 46 patients who received peripheral stem cell grafts
from HLA-identical donors after myeloablative conditioning. In
27 patients with .220/ul CD4 T cells at 6 months, both Tcon and
Treg gradually increased over the subsequent 18 months. In con-
trast, in 19 patients with\220/ul CD4 T cells at 6 months, Tcon
gradually increased but Treg decreased over the subsequent 12–24
months. These results indicate that Treg reconstitution is character-
ized by increased peripheral proliferation but this is counterbalanced
by increased sensitivity to apoptosis. These characteristics are more
